Related references
Note: Only part of the references are listed.Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response
Peidi Yin et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Unexpected intracellular biodegradation and recrystallization of gold nanoparticles
Alice Balfourier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Influence of Gold Nanoparticles with Different Surface Charges on Localization and Monocyte Behavior
Sukanya Srijampa et al.
BIOCONJUGATE CHEMISTRY (2020)
Nasal administration of nanoencapsulated geraniol/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease
Edilson Ribeiro de Oliveira Junior et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Stimuli-responsive In situ gelling system for nose-to-brain drug delivery
Mukta Agrawal et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Gold-based Inorganic Nanohybrids for Nanomedicine Applications
Xianguang Ding et al.
THERANOSTICS (2020)
Ultrastructural and optical characteristics of cancer cells treated by a nanotechnology based chemo-photothermal therapy method
Zahra Alamzadeh et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2019)
Acquired temozolomide resistance in MGMT-deficient glioblastoma cells is associated with regulation of DNA repair by DHC2
Guo-Zhong Yi et al.
BRAIN (2019)
Nitric Oxide Stimulated Programmable Drug Release of Nanosystem for Multidrug Resistance Cancer Therapy
Li Wang et al.
NANO LETTERS (2019)
Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma
Maleeha A. Qazi et al.
CANCER RESEARCH (2018)
Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics
Vassilis Bourganis et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
Theranostic size-reducible and no donor conjugated gold nanocluster fabricated hyaluronic acid nanoparticle with optimal size for combinational treatment of breast cancer and lung metastasis
Rui Liu et al.
JOURNAL OF CONTROLLED RELEASE (2018)
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma
Claudio Festuccia et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Temozolomide for immunomodulation in the treatment of glioblastoma
Aida Karachi et al.
NEURO-ONCOLOGY (2018)
Effect of Retro-Inverso Isomer of Bradykinin on Size-Dependent Penetration of Blood-Brain Tumor Barrier
Bingxia Su et al.
SMALL (2018)
Nose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting
Liuxiang Chu et al.
DRUG DELIVERY (2018)
Focused ultrasound combined with microbubble-mediated intranasal delivery of gold nanoclusters to the brain
Dezhuang Ye et al.
JOURNAL OF CONTROLLED RELEASE (2018)
EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma
Carolin Offenhauser et al.
CANCERS (2018)
Progress in brain targeting drug delivery system by nasal route
Abdur Rauf Khan et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433)
Sonali Kumari et al.
SCIENTIFIC REPORTS (2017)
In Vivo Neuroimaging of Exosomes Using Gold Nanoparticles
Oshra Betzer et al.
ACS NANO (2017)
EphA3 promotes malignant transformation of colorectal epithelial cells by upregulating oncogenic pathways
Mingqi Li et al.
CANCER LETTERS (2016)
Temozolomide resistance in glioblastoma multiforme
Sang Y. Lee
GENES & DISEASES (2016)
Trans-Blood Brain Barrier Delivery of Dopamine-Loaded Nanoparticles Reverses Functional Deficits in Parkinsonian Rats
Richa Pahuja et al.
ACS NANO (2015)
Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles
Shaobo Ruan et al.
BIOMATERIALS (2015)
Brain targeted intranasal delivery of tramadol: comparative study of microemulsion and nanoemulsion
Jigar Lalani et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2015)
Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment
Huile Gao et al.
BIOMATERIALS (2014)
Endocytosis and exocytosis of nanoparticles in mammalian cells
Nuri Oh et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
MGMT gene silencing by promoter hypermethylation in gastric cancer in a high incidence area
Adfar Yousuf et al.
CELLULAR ONCOLOGY (2014)
Nanotechnology as a therapeutic tool to combat microbial resistance
Robert Y. Pelgrift et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
The performance of thiol-terminated PEG-paclitaxel-conjugated gold nanoparticles
Ya Ding et al.
BIOMATERIALS (2013)
EphA3 Maintains Tumorigenicity and Is a Therapeutic Target in Glioblastoma Multiforme
Bryan W. Day et al.
CANCER CELL (2013)
Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles
Anamaria Orza et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2013)
Surface Functionalized Gold Nanoparticles for Drug Delivery
Jinping Cheng et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2013)
Intranasal delivery of biologics to the central nervous system
Jeffrey J. Lochhead et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
The reverse of polymer degradation: in situ crosslinked gel formation through disulfide cleavage
Aram O. Saeed et al.
CHEMICAL COMMUNICATIONS (2012)
Effects of Cancer-Associated EPHA3 Mutations on Lung Cancer
Guanglei Zhuang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Gold-doxorubicin nanoconjugates for overcoming multidrug resistance
Yan-Juan Gu et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
Doxorubicin-Tethered Responsive Gold Nanoparticles Facilitate Intracellular Drug Delivery for Overcoming Multidrug Resistance in Cancer Cells
Feng Wang et al.
ACS NANO (2011)
Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas
Marc C. Chamberlain
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
Hypofraktionierte Rebestrahlung bei rezidivierten malignen Gliomen
Guido Henke et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2009)
Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177
Paul D. Brown et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
MGMT in primary and recurrent human glioblastomas after radiation and chemotherapy and comparison with p53 status and clinical outcome
Dorothee Wiewrodt et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Novel therapies for malignant gliomas
Robert Cavaliere et al.
NEUROLOGIC CLINICS (2007)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity
EE Connor et al.
SMALL (2005)
Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial
M Reni et al.
EUROPEAN JOURNAL OF CANCER (2004)
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
WKA Yung et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
